Common worm drug tested for bowel disease control
NCT ID NCT06335160
Summary
This study is testing whether adding mebendazole, a medication typically used for parasitic worm infections, helps people with mild-to-moderate ulcerative colitis who are already taking standard mesalamine treatment. Researchers will compare two groups of 23 patients each over six months to see if the combination reduces bowel inflammation and symptoms better than the standard treatment alone. The goal is to find a new way to better control this chronic inflammatory bowel disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tanta Unuversity
RECRUITINGTanta, 34518, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.